Trial Profile
A study to evaluate Enoblituzumab as a monotherapy in children with neuroblastoma and other tumors
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2016
Price :
$35
*
At a glance
- Drugs Enoblituzumab (Primary)
- Indications Neuroblastoma
- Focus Therapeutic Use
- 18 Nov 2016 New trial record